Latest Dividend Declaration News

Locate Technologies Limited reported a significant reduction in losses for FY2025, driven by strong growth in its Locate2u segment and effective cost management.

The company posted a 25% increase in net loss to $709,247 for the year ended June 2025, alongside a sharp 55% drop in revenue. Key factors include significant trading losses and lower interest income, with no dividends declared.

BHP Group Limited has updated its dividend announcement, confirming a fully franked USD 0.60 per share dividend for the half-year ending June 2025 and providing the South African Rand exchange rate ahead of payment.

Eneco Refresh Limited has reversed its fortunes with a modest profit in FY25, driven by steady revenue growth and operational improvements across key regions and business units.

Kinatico Limited has reported a robust 12% increase in revenue and a striking 45% rise in profit after tax for the financial year ended June 2025, underscoring solid operational momentum despite no dividend payouts.

CVC Limited has reversed its fortunes with a $0.5 million net profit after tax for FY25, driven by strong property investment income and strategic land developments, while maintaining a cautious capital management approach and withholding dividends.

Star Combo Pharma has reported a remarkable jump in profit for FY2025, driven by strong revenue growth and a settled insurance claim, while declaring its second dividend and planning production expansion.

Calix Limited reported a $20.1 million loss for FY2025 despite an 11.2% increase in revenue, reflecting ongoing investment in its industrial decarbonisation technology platform.

Integral Diagnostics posts robust FY25 results with strong revenue growth and merger synergies exceeding expectations, setting a confident tone for FY26.

Propel Funeral Partners reported a solid 14.5% increase in statutory profit for FY25, driven by strategic acquisitions despite a slowdown in death volumes. The company also declared a fully franked final dividend of 7.0 cents per share.

Chrysos Corporation reported a robust 46% revenue increase to A$66.1 million for FY25 but faced a significant net loss of A$8.2 million, reflecting rising costs and operational challenges.

Austco Healthcare has reported a robust FY25 with revenues climbing 40% to $81.4 million and EBITDA jumping 62% to $13 million, driven by organic growth and strategic acquisitions.